APA (7th ed.) Citation

RE, M., JK, T., JM, K., JM, N., GA, M., JM, N., . . . R, B. (2009). Efficacy of the novel diamidine compound 2,5-Bis(4-amidinophenyl)- furan-bis-O-Methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration. Antimicrobial agents and chemotherapy, 53(3), 953. https://doi.org/10.1128/AAC.00831-08

Chicago Style (17th ed.) Citation

RE, Mdachi, Thuita JK, Kagira JM, Ngotho JM, Murilla GA, Ndung'u JM, Tidwell RR, Hall JE, and Brun R. "Efficacy of the Novel Diamidine Compound 2,5-Bis(4-amidinophenyl)- Furan-bis-O-Methlylamidoxime (Pafuramidine, DB289) Against Trypanosoma Brucei Rhodesiense Infection in Vervet Monkeys After Oral Administration." Antimicrobial Agents and Chemotherapy 53, no. 3 (2009): 953. https://doi.org/10.1128/AAC.00831-08.

MLA (9th ed.) Citation

RE, Mdachi, et al. "Efficacy of the Novel Diamidine Compound 2,5-Bis(4-amidinophenyl)- Furan-bis-O-Methlylamidoxime (Pafuramidine, DB289) Against Trypanosoma Brucei Rhodesiense Infection in Vervet Monkeys After Oral Administration." Antimicrobial Agents and Chemotherapy, vol. 53, no. 3, 2009, p. 953, https://doi.org/10.1128/AAC.00831-08.